CN107441352B - Traditional Chinese medicine for treating epilepsy - Google Patents
Traditional Chinese medicine for treating epilepsy Download PDFInfo
- Publication number
- CN107441352B CN107441352B CN201710916558.8A CN201710916558A CN107441352B CN 107441352 B CN107441352 B CN 107441352B CN 201710916558 A CN201710916558 A CN 201710916558A CN 107441352 B CN107441352 B CN 107441352B
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- chinese medicine
- epilepsy
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Zoology (AREA)
- Developmental Biology & Embryology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Marine Sciences & Fisheries (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
A Chinese medicinal composition for treating epilepsia. Epilepsy is a chronic disease, can repeatedly attack the abnormal condition of mind, is called epilepsy wind in folk times, is clinically characterized by sudden consciousness loss, tetany, spitting of white foam, sight on eyes, tooth clenching and bluish lips, is a common chronic attack disease of nervous system, and has a trend of increasing year by year in recent years. A traditional Chinese medicine for treating epileptic diseases is prepared from the following raw materials in parts by weight: 5 parts of cordyceps sinensis, 5 parts of American ginseng, 5 parts of wild ganoderma lucidum, 5 parts of raw oyster, 5 parts of dendrobium officinale, 10 parts of schisandra chinensis, 10 parts of chinaroot greenbrier rhizome, 10 parts of spina date seed, 5 parts of pilose antler, 20 parts of abalone shell and 5 parts of raw liquorice. The invention is applied to the traditional Chinese medicine treatment of epilepsy.
Description
Technical Field
The invention relates to a traditional Chinese medicine for treating epilepsy.
Background
Epilepsy is a chronic disease, can repeatedly attack the abnormal condition of mind, is called epilepsy wind in folk times, is clinically characterized by sudden consciousness loss, tetany, spitting of white foam, sight on eyes, tooth clenching and bluish lips, is a common chronic attack disease of nervous system, and has a trend of increasing year by year in recent years.
At present, the clinical treatment methods for treating the disease comprise acupuncture, drug therapy and the like, while the drug therapy mainly comprises western medicines which can only relieve surface symptoms, have large toxic and side effects and have unsatisfactory curative effect. The traditional Chinese medicine can treat the symptoms and root causes, eliminate diseases and strengthen the body, has no side effect and has a large application market.
Disclosure of Invention
The invention aims to provide a traditional Chinese medicine for treating epilepsy, which is prepared by processing cordyceps sinensis, American ginseng, wild ganoderma lucidum, raw oyster shell, dendrobium officinale, schisandra chinensis, white poria, spina date seed, pilose antler, abalone shell and raw liquorice according to a certain compatibility requirement according to the traditional Chinese medicine theory, has no side effect and does not relapse after recovery.
The above purpose is realized by the following technical scheme:
a traditional Chinese medicine for treating epilepsy comprises the following components: the composition is prepared from the following raw materials in parts by weight: 5-10 parts of cordyceps sinensis, 5-10 parts of American ginseng, 5-10 parts of wild ganoderma lucidum, 5-10 parts of raw oyster, 5-10 parts of dendrobium officinale, 10-20 parts of schisandra chinensis, 10-20 parts of chinaroot greenbrier rhizome, 10-20 parts of spina date seed, 5-10 parts of pilose antler, 20-30 parts of abalone shell and 5-10 parts of raw liquorice.
The traditional Chinese medicine for treating the epilepsy is prepared from the following raw materials in parts by weight: 5 parts of cordyceps sinensis, 5 parts of American ginseng, 5 parts of wild ganoderma lucidum, 5 parts of raw oyster, 5 parts of dendrobium officinale, 10 parts of schisandra chinensis, 10 parts of chinaroot greenbrier rhizome, 10 parts of spina date seed, 5 parts of pilose antler, 20 parts of abalone shell and 5 parts of raw liquorice.
The traditional Chinese medicine for treating the epilepsy is prepared from the following raw materials in parts by weight: 10 parts of cordyceps sinensis, 10 parts of American ginseng, 10 parts of wild ganoderma lucidum, 10 parts of raw oyster, 10 parts of dendrobium officinale, 20 parts of schisandra chinensis, 20 parts of chinaroot greenbrier rhizome, 20 parts of spina date seed, 10 parts of pilose antler, 30 parts of abalone shell and 10 parts of raw liquorice.
The traditional Chinese medicine for treating the epilepsy comprises the following components: the composition is prepared from the following raw materials in parts by weight: 7 parts of cordyceps sinensis, 7 parts of American ginseng, 7 parts of wild ganoderma lucidum, 7 parts of raw oyster, 7 parts of dendrobium officinale, 15 parts of schisandra chinensis, 15 parts of chinaroot greenbrier rhizome, 15 parts of spina date seed, 7 parts of pilose antler, 25 parts of abalone shell and 7 parts of raw liquorice.
The preparation method of the traditional Chinese medicine for treating the epileptic disease comprises the following steps:
(1) and (3) purification treatment:
the method of picking, sorting, winnowing, sieving, brushing and the like is adopted to remove dust, impurities and non-medicinal parts, so that the medicine is clean and pure.
(2) Mixing treatment:
mixing the pure Cordyceps, radix Panacis Quinquefolii, wild Ganoderma, Concha Ostreae, herba Dendrobii, fructus Schisandrae chinensis, Poria, semen Ziziphi Spinosae, cornu Cervi Pantotrichum, Concha Haliotidis and Glycyrrhrizae radix.
(3) And (3) crushing treatment:
mixing the medicines, and pulverizing the mixed medicines into 200-mesh powder by a powder grinding machine.
(4) Charging treatment:
the medicine which is crushed into 200 meshes of powder is filled into capsules and sealed, and the capsules with 0.05 g/grain are prepared.
The invention has the following beneficial effects:
1. the invention treats both principal and secondary aspect of disease, has obvious effects of benefiting liver and kidney, dispelling wind and arresting epilepsy, suppressing hyperactive liver and extinguishing phoenix, reducing the attack time and frequency of epilepsy disease through clinical examination, and finally achieves the aim of recovery without attack.
2. Clinical application proves that the Chinese medicament for treating the epilepsy disease is safe, non-toxic, short in curative effect, quick in response and free of recurrence after healing, can improve clinical symptoms of epilepsy patients, reduces morbidity time and frequency, achieves the aim of healing without morbidity, and is a pure Chinese medicinal preparation.
3. The traditional Chinese medicine has a simple formula, and the raw materials are reasonably compatible and complement each other, can be used for treating based on syndrome differentiation, and particularly has a good treatment effect on epilepsy due to fright caused by fright and epilepsy due to internal heat. The traditional Chinese medicine is generally prepared into capsules of 0.05 g/capsule, and the capsules are orally taken one time and three times a day, and a treatment course lasts for 15 days.
4. The invention discloses a cordyceps sinensis: it has effects of tonifying lung and kidney, stopping bleeding and eliminating phlegm, and is indicated for chronic cough, dyspnea due to deficiency, cough with phlegm and blood, soreness of waist and knees, impotence and spermatorrhea.
American ginseng: has effects in invigorating qi, nourishing yin, clearing pathogenic fire, and promoting fluid production, and can be used for treating deficiency of body fluid and qi deficiency such as chronic cough due to lung deficiency, asthma, excessive phlegm, fever due to asthenia, dry throat, and dry tongue.
Wild ganoderma lucidum: sweet and neutral, can replenish vital essence and energy, stop cough and dyspnea, benefit joint and induce tranquilization, and are commonly used for consumptive disease, cough, asthma, insomnia, dyspepsia, coronary heart disease, arrhythmia and other symptoms.
Raw oyster shells: entering liver and kidney meridians, has the functions of calming liver and suppressing yang hyperactivity, resolving hard mass and softening hard mass, and astringing and arresting discharge, and is commonly used for treating liver yang dizziness, dysphoria, palpitation and insomnia, tinnitus, spermatorrhea, spontaneous perspiration and night sweat.
Dendrobium officinale: entering stomach and kidney meridians, it has the actions of nourishing stomach, promoting the production of body fluid, nourishing yin and removing heat, and is commonly indicated for body fluid impairment due to febrile diseases, stomach yin deficiency, dry tongue, thirst, yin deficiency, body fluid deficiency, and persistent deficient heat.
Schisandra chinensis: relieving cough, astringing, nourishing kidney, and promoting fluid production, and is commonly used for cough, asthma, diarrhea, night sweat, spermatorrhea, body fluid injury, and thirst.
White poria: sweet and neutral, entering heart, lung, spleen, stomach and kidney meridians, are commonly indicated for inducing diuresis and excreting dampness, strengthening spleen and tonifying middle-jiao, calming heart and tranquilizing mind.
Wild jujube seed: sweet, sour and neutral, entering heart and liver meridians, they have the actions of nourishing heart, tranquilizing mind and arresting sweating, and are commonly indicated for restlessness and insomnia, palpitation and amnesia, dizziness and sweating due to deficiency.
Pilose antler: enter liver and kidney meridians, tonify governor vessel, strengthen yang, generate bone marrow and strengthen tendons and bones.
Abalone shell: entering liver meridian, pacifying liver and subduing yang, clearing liver heat and improving vision, it is commonly indicated for dizziness, vertigo, convulsion, conjunctival congestion, swelling and pain, blurred vision.
Raw licorice root: sweet and neutral, and nontoxic, so it is commonly used for internal organs, cold and heat pathogens, strengthening tendons and bones, growing muscles, dredging meridians, promoting blood and qi circulation, and removing various drug toxins.
Detailed Description
The following description is presented in conjunction with the preferred embodiments of the present invention, and it is to be understood that the preferred embodiments described herein are presented only for the purpose of illustrating and explaining the present invention, and are not intended to limit the present invention.
Example 1:
a traditional Chinese medicine for treating epilepsy comprises the following components: the composition is prepared from the following raw materials in parts by weight: 5-10 parts of cordyceps sinensis, 5-10 parts of American ginseng, 5-10 parts of wild ganoderma lucidum, 5-10 parts of raw oyster, 5-10 parts of dendrobium officinale, 10-20 parts of schisandra chinensis, 10-20 parts of chinaroot greenbrier rhizome, 10-20 parts of spina date seed, 5-10 parts of pilose antler, 20-30 parts of abalone shell and 5-10 parts of raw liquorice.
Example 2:
the traditional Chinese medicine for treating the epilepsy according to the embodiment 1 is prepared from the following raw materials in parts by weight: 5 parts of cordyceps sinensis, 5 parts of American ginseng, 5 parts of wild ganoderma lucidum, 5 parts of raw oyster, 5 parts of dendrobium officinale, 10 parts of schisandra chinensis, 10 parts of chinaroot greenbrier rhizome, 10 parts of spina date seed, 5 parts of pilose antler, 20 parts of abalone shell and 5 parts of raw liquorice.
Example 3:
the traditional Chinese medicine for treating the epilepsy according to the embodiment 1 or 2 is prepared from the following raw materials in parts by weight: 10 parts of cordyceps sinensis, 10 parts of American ginseng, 10 parts of wild ganoderma lucidum, 10 parts of raw oyster, 10 parts of dendrobium officinale, 20 parts of schisandra chinensis, 20 parts of chinaroot greenbrier rhizome, 20 parts of spina date seed, 10 parts of pilose antler, 30 parts of abalone shell and 10 parts of raw liquorice.
Example 4:
the traditional Chinese medicine for treating epilepsy according to embodiment 1, 2 or 3, comprises the following raw materials in parts by weight: 7 parts of cordyceps sinensis, 7 parts of American ginseng, 7 parts of wild ganoderma lucidum, 7 parts of raw oyster, 7 parts of dendrobium officinale, 15 parts of schisandra chinensis, 15 parts of chinaroot greenbrier rhizome, 15 parts of spina date seed, 7 parts of pilose antler, 25 parts of abalone shell and 7 parts of raw liquorice.
The specific cases are as follows:
jia, male, 60 years old, Haerbin, Magnolia county, Toddangcun farmers. Epilepsy, sudden loss of consciousness, tetany, spitting foam in mouth, awakening after 5 minutes, and attack 6 times a day in 1967. The oral traditional Chinese medicine for treating epilepsy of the invention can heal after two courses of treatment.
Li Yi, woman, 46 years old, Haerbin, Magnoliae county, Toddangcun farmers. In 1985, epilepsy suffered from epilepsy and suddenly appeared faint, white foam and purple face, and the disease condition is good and bad after long-term medical inquiry treatment. The medicine can be taken for two courses of treatment to heal.
Consider a certain, female, 48 years old, farmers in Longjiang village, a big and precious town of Mulan county, Harbin. In 1979, epilepsy was observed, with generalized convulsions, unclear consciousness and incontinence of urine and stool. The medicine can be taken for one treatment course to cure the disease.
Peasants in Betula village, Mulan county, Oldham, 61 Wen years old. In 1986, epilepsy was felt, which caused the onset of the disease, the teeth were tightly closed, which was not easy to be done, and white foam was spitted out. After the traditional Chinese medicine is taken for one course of treatment, the patients can be cured.
Chen in Chen, Man, 50 years old, Haerbin, Magnolia county, big town employee. In 1980, epilepsy had manifested as convulsion of limbs, eye blockage, abnormal sound in mouth, facial palsy, and bluish lips. The Chinese medicament can be taken orally for a treatment course to heal.
Claims (4)
1. A traditional Chinese medicine for treating epileptic diseases is prepared from the following raw materials in parts by weight: 5-10 parts of cordyceps sinensis, 5-10 parts of American ginseng, 5-10 parts of wild ganoderma lucidum, 5-10 parts of raw oyster, 5-10 parts of dendrobium officinale, 10-20 parts of schisandra chinensis, 10-20 parts of chinaroot greenbrier rhizome, 10-20 parts of spina date seed, 5-10 parts of pilose antler, 20-30 parts of abalone shell and 5-10 parts of raw liquorice;
the preparation method of the traditional Chinese medicine for treating the epilepsy comprises the following steps:
(1) and (3) purification treatment:
picking, sorting, winnowing, screening and brushing are adopted to remove dust, impurities and non-medicinal parts, so that the medicine is clean and pure;
(2) mixing treatment:
mixing the pure Cordyceps, radix Panacis Quinquefolii, wild Ganoderma, Concha Ostreae, herba Dendrobii, fructus Schisandrae chinensis, Poria, semen Ziziphi Spinosae, cornu Cervi Pantotrichum, Concha Haliotidis and Glycyrrhrizae radix;
(3) and (3) crushing treatment:
mixing the medicines, and pulverizing the mixed medicines into 200-mesh powder by a powder grinding machine;
(4) charging treatment:
the medicine which is crushed into 200 meshes of powder is filled into capsules and sealed, and the capsules with 0.05 g/grain are prepared.
2. The traditional Chinese medicine for treating epilepsy as claimed in claim 1, wherein: the composition is prepared from the following raw materials in parts by weight: 5 parts of cordyceps sinensis, 5 parts of American ginseng, 5 parts of wild ganoderma lucidum, 5 parts of raw oyster, 5 parts of dendrobium officinale, 10 parts of schisandra chinensis, 10 parts of chinaroot greenbrier rhizome, 10 parts of spina date seed, 5 parts of pilose antler, 20 parts of abalone shell and 5 parts of raw liquorice.
3. The traditional Chinese medicine for treating epilepsy as claimed in claim 1, wherein: the composition is prepared from the following raw materials in parts by weight: 10 parts of cordyceps sinensis, 10 parts of American ginseng, 10 parts of wild ganoderma lucidum, 10 parts of raw oyster, 10 parts of dendrobium officinale, 20 parts of schisandra chinensis, 20 parts of chinaroot greenbrier rhizome, 20 parts of spina date seed, 10 parts of pilose antler, 30 parts of abalone shell and 10 parts of raw liquorice.
4. The traditional Chinese medicine for treating epilepsy as claimed in claim 1, wherein: the composition is prepared from the following raw materials in parts by weight: 7 parts of cordyceps sinensis, 7 parts of American ginseng, 7 parts of wild ganoderma lucidum, 7 parts of raw oyster, 7 parts of dendrobium officinale, 15 parts of schisandra chinensis, 15 parts of chinaroot greenbrier rhizome, 15 parts of spina date seed, 7 parts of pilose antler, 25 parts of abalone shell and 7 parts of raw liquorice.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710916558.8A CN107441352B (en) | 2017-09-30 | 2017-09-30 | Traditional Chinese medicine for treating epilepsy |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710916558.8A CN107441352B (en) | 2017-09-30 | 2017-09-30 | Traditional Chinese medicine for treating epilepsy |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107441352A CN107441352A (en) | 2017-12-08 |
CN107441352B true CN107441352B (en) | 2020-12-15 |
Family
ID=60497693
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710916558.8A Active CN107441352B (en) | 2017-09-30 | 2017-09-30 | Traditional Chinese medicine for treating epilepsy |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107441352B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103446364A (en) * | 2012-05-27 | 2013-12-18 | 孙玉建 | Traditional Chinese medicine for treating epilepsy |
CN105878850A (en) * | 2016-06-02 | 2016-08-24 | 成都风靡生物科技有限公司 | Drug pills for treating heart-blood deficiency disease and preparation method thereof |
-
2017
- 2017-09-30 CN CN201710916558.8A patent/CN107441352B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103446364A (en) * | 2012-05-27 | 2013-12-18 | 孙玉建 | Traditional Chinese medicine for treating epilepsy |
CN105878850A (en) * | 2016-06-02 | 2016-08-24 | 成都风靡生物科技有限公司 | Drug pills for treating heart-blood deficiency disease and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN107441352A (en) | 2017-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102755593A (en) | Traditional Chinese medicine composition for treating qi goiter and preparation method thereof | |
CN102228626B (en) | Traditional Chinese medicine for treating tinnitus and deafness | |
CN105663656A (en) | Pharmaceutical composition for treating sleep disorders and preparing method thereof | |
CN104225194A (en) | Traditional Chinese medicine for treating insomnia | |
CN105362491A (en) | External-use medicine for treating cervical vertebra hyperosteogeny | |
CN105878574B (en) | It is a kind of to treat Chinese medicine composition of kidney deficiency and preparation method thereof | |
CN102370943A (en) | Chinese herbal medicine used for treating neurasthenia | |
CN107441352B (en) | Traditional Chinese medicine for treating epilepsy | |
CN104352821A (en) | Traditional Chinese medicine granule for treating hypertension | |
CN102961575A (en) | Formula of traditional Chinese medicine for treating viral cardiac neurosis | |
CN103405637B (en) | Drug for treating neurosis and preparation method thereof | |
CN103751301B (en) | For the goods of aseptic necrosis of femoral head patient | |
CN102327459A (en) | Chinese herbal medicine for treating liver/kidney yin deficiency neurasthenia | |
CN102293941B (en) | Chinese medicinal composition for treating diabetes mellitus | |
CN104548020A (en) | Application of medicine composition in preparing medicine curing senile dementia | |
CN104173775A (en) | Traditional Chinese medicine composition for treating cervicogenic headache and preparation method of traditional Chinese medicine composition | |
CN102626503B (en) | Chinese medicinal oral liquid for smoothing heart and enhancing intelligence | |
CN103989806B (en) | A kind of medicine for the treatment of osteoporosis and preparation method thereof | |
CN103169886B (en) | Traditional Chinese medicine composition for treating infantile convulsions | |
CN106266711A (en) | A kind of endo-medicine treating deafness and tinnitus and preparation method thereof | |
CN104324164A (en) | Traditional Chinese medicine composition for nursing of cerebral concussion sequelae | |
CN105878738A (en) | Traditional Chinese medicine composition for treating qi and blood deficiency syndrome and preparation method thereof | |
CN105012622A (en) | Beverage for treating insomnia | |
CN104474200A (en) | Orally taken traditional Chinese medicinal liquid for treating Adie syndrome and preparation method thereof | |
CN105213532A (en) | A kind of Chinese medicine oral liquid and preparation method for the treatment of lumbar vertebra pain |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |